EstechPharma Co. Ltd (041910) — Cash Flow-to-Debt Ratio
EstechPharma Co. Ltd (041910) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩2.38 Billion could theoretically repay 0% of its total liabilities (₩60.00 Billion) in one year. See EstechPharma Co. Ltd (041910) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
EstechPharma Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for EstechPharma Co. Ltd across 13 annual periods. Also explore how fast is EstechPharma Co. Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for EstechPharma Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for EstechPharma Co. Ltd. For market capitalisation and broader financial context, see 041910 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | ₩8.83 Billion | ₩60.00 Billion | ▼ -89.1% |
| 2024 | 1.35x | ₩7.93 Billion | ₩5.87 Billion | ▲ +76.9% |
| 2023 | 0.76x | ₩4.79 Billion | ₩6.27 Billion | ▲ +481.2% |
| 2022 | -0.20x | ₩-1.65 Billion | ₩8.23 Billion | ▼ -467.5% |
| 2021 | 0.05x | ₩603.42 Million | ₩11.06 Billion | ▼ -86.4% |
| 2020 | 0.40x | ₩4.71 Billion | ₩11.76 Billion | ▲ +28.0% |
| 2019 | 0.31x | ₩4.29 Billion | ₩13.71 Billion | ▼ -60.7% |
| 2018 | 0.80x | ₩7.25 Billion | ₩9.09 Billion | ▲ +43.4% |
| 2017 | 0.56x | ₩6.99 Billion | ₩12.57 Billion | ▲ +36.2% |
| 2016 | 0.41x | ₩8.19 Billion | ₩20.05 Billion | ▼ -24.9% |
| 2015 | 0.54x | ₩10.46 Billion | ₩19.24 Billion | ▲ +320.0% |
| 2014 | 0.13x | ₩4.99 Billion | ₩38.57 Billion | ▼ -53.7% |
| 2013 | 0.28x | ₩10.19 Billion | ₩36.41 Billion | — |